preclinomics , inc
Post on 25-Feb-2016
36 Views
Preview:
DESCRIPTION
TRANSCRIPT
The ZDSD Rat as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes that Demonstrates Many of the Serious Complications of Diabetes.
PreClinOmics, Inc.
1
Metabolic Syndrome affects a large proportion of the population and is becoming increasingly important in adolescents. The syndrome has many components including central obesity, insulin resistance, dyslipidemia and hypertension. In addition, the syndrome features a chronic low grade inflammatory state, vascular endothelial dysfunction, and a prothrombotic environment. Long standing metabolic syndrome can thus pre-dispose to atherosclerosis, microvasculature disease (retina), stroke, renal injury and diabetes. Due to the complicated mechanisms involved in the syndrome and its sequelae, current standard of care reflects poly-pharmacy and is aimed at controlling atherogenic dyslipidemia, hyperglycemia and hypertension as well as intervening in secondary diseases such as renal dysfunction, stroke, and micro-vascular disease related to retinopathy. Development of new chemical entities with the potential to control more than one risk factor is hampered by currently available animal models. To that end, the ZDSD rat was designed to spontaneously develop a phenotype that mimics many aspects of the human metabolic syndrome, including hypertension and the progression to frank diabetes with long-standing disease.
ZDSD as a Preclinical Model of Metabolic Syndrome
2
Development Scheme: Zucker Diabetic-Sprague Dawley Rat (ZDSD)• Produced by crossing diet induced obese (DIO) rats
derived from the Crl:CD (SD) strain (exhibiting polygenetic obesity and insulin resistance) with homozygous lean ZDF/Crl rats (which expresses beta cell failure with the Leprfa/Leprfa genotype).
• Selectively bred for obesity and diabetes.• Selected for genetically matched breeders to
develop phenotypic homogeneity.• Studied male rats at different ages.
3
Characteristics of Metabolic Syndrome seen in the ZDSD Rat
• Increased body weight with increased abdominal fat• Increased fed and fasting glucose and HbA1c levels• Insulin resistance / Glucose intolerance• Hyperlipidemia• Increased blood pressure --> Hypertension• Increased Serum Biomarkers of Coagulation,
Inflammation and Vascular Disease
4
Comparative Growth Curvesin SD and ZDSD Rat Fed 5008 chow
ZDSD rats were significantly (15%) heavier than their SD counterparts at 8 weeks of age. In addition, the rate of body weight gain was increased in ZDSD rats as evidenced by an 82% vs 62% weight gain when compared to SD rats over 24 weeks of observation.
Study # 09-550-170
All time points statistically different
5
Spontaneous Development of Obesity in ZDSD Rats Fed 5008 Chow
Study # 09-550-170
All time points statistically different
Body composition was assessed using QNMR . The percentage of body weight identified as fat was 50 % higher in ZDSD rats compared to SD controls as early as 8 weeks of age. Body fat percentage continued to increase throughout the study and remained significantly higher than control rats at each time-point.
6
Spontaneous Development of Hyperglycemia in ZDSD Rats Fed 5008 Chow
Study # 09-550-170
All time points statistically different
7
Spontaneous Development of Glucose Intolerance Shown by OGTT in ZDSD Rats Fed 5008 Chow
8
ZDSD rats become increasingly more insulin resistant with age as evidenced by the calculated HOMA-IR. The insulin resistance is evident compared to SD rats as early as 8 weeks of age (fed Purina 5008 chow).
Progressive Development of Insulin Resistance (HOMA-IR) in ZDSD Rats
All time points statistically different
9
Representative Islets from 28 wk old ZDSD Rats
Pre-diabetic Diabetic
10
Blood pressure data produced in collaboration with Dr. Subah Packer’s Laboratory, IU School of Medicine
Blood Pressure in ZDSD vs CD Rats8-16 weeks of age
11
60 70 80 90 10080
100
120
140
160ZDSDCD
Age in Days
Syst
olic
BP
(mm
Hg)
Urinary albumin
10 20 22 24 26 300
25
50
75
100
125
150SDZDSD
Age (weeks)
Urin
ary
albu
min
(mg/
day)
beta-2 microglobulin
10 20 22 24 26 300
500
1000
1500
2000 SDZDSD
Age (weeks)
Urin
ary
b-2 m
icro
glob
ulin
( mg/da
y)
Cystatin C
10 20 22 24 26 300
10
20
30SDZDSD
Age (weeks)
Urin
ary
cyst
atin
C ( mg/
day)
KIM-1
10 20 22 24 26 300.0
2.5
5.0
7.5
10.0
12.5
15.0SDZDSD
Age (weeks)
Urin
ary
KIM
-1 (n
g/da
y)
Time Course of Urinary Biomarkers
12
Glomerular Basement Membrane Thickness
Time of Diabetes in the ZDSD Rat
Thic
knes
s (m
m)
CD Control 12 Weeks 16.5 Weeks0
100
200
300
400
500
13
Kidney Histopathology of the ZDSD Rat
Glomerulopathy Tubular dilation Protein casts Inflammation
His
topa
thol
ogy
Sco
re (0
-5)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0Non-diabetic Diabetic
* * **
* compared to Non-diabetic animals(t-test p<0.05)
/degeneration
14
Wound Healing in the ZDSD Rat
This figure demonstrates the wound healing in the three groups of animals. There were no differences between diabetic and non-diabetic ZDSD animals. There were several statistically significant differences between the SD group and the ZDSD groups (* p<0.05). Since the data were not different in the ZDSD groups there were also analyzed as a combined group.
15
Separated Diabetic and Non-Diabetic ZDSD
4 7 9 11 14-100
-80
-60
-40
-20
0 SDDiabetic ZDSD
Non-Diabetic ZDSD
**
**
*
*
*
*compared to SD (Dunnett's)
Time(days) post-wounding
% C
hang
e Fr
om In
iital
Wou
nd
Combined ZDSD Data
4 7 9 11 14-100
-80
-60
-40
-20
0SD
ZDSD
*
*
* *
*
*compared to SD (t-test)
Time(days) post-wounding
% C
hang
e Fr
om In
iital
Wou
nd
Structural Properties L4 vertebraeP-values for differences in diabetic rats vs. respective controls
Mean ±SEMn=12-17/group
16
0102030405060708090
ZDF (fa/fa) ZDF (+/fa)
Ene
rgy
to U
ltim
ate
Load
(mJ)
*
Biomechanical Test – axial compression ZDF ZDSD Yield Force (N) p<0.050 p<0.001Stiffness (N/mm) p<0.001 p<0.005
Ultimate Load (N) p<0.001 p<0.001Energy to Ultimate Load (mJ) p<0.050 p<0.001
0
10
20
30
40
50
60
70
8090
ZDSD Controls
Ene
rgy
to U
ltim
ate
Load
(mJ)
*
ZDSDObesity
Metabolic SyndromeDiabetes
Obesity Modelbefore
diabetes develops,5-16 weeks of age
Metabolic Syndrome
Insulin Resistance
Hyperlipidemia
Obesity
Hypertension
Delayed Wound Healing
Diabetes Models
SpontaneousDevelopment
(LabDiet 5008; Slower & more random)
Diabetic Nephropathy
Osteoporosis
Cardiovascular/ Inflammatory Biomarkers
Delayed Wound Healing
Diet Synchronized
(RD D12468 or TestDiet 5SCA)
Diabetic Nephropathy
Osteoporosis
Cardiovascular/ Inflammatory Biomarkers
Delayed Wound Healing
The ZDSD Rat: One Rat – Many Models
17
ZDSD Summary- One Rat, Many Models
• Polygenic phenotype that can be modulated by diet• Functional Leptin Pathway• Early onset of hyperglycemia with slower
progression to frank diabetes when compared to the ZDF rat
• Mirrors human development of type II diabetes• Manifests diabetic complications:
• Diabetic nephropathy• Hypertension• Inflammation• Osteoporosis• Delayed wound healing
1818
top related